SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

Virtual Reality Travel Reduces Cancer Pain.

4.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

5.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot